A Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Single and Multiple Doses of AL002 in Healthy Participants and in Participants with Mild to Moderate Alzheimer's Disease.

Project: Research

Project Details

StatusFinished
Effective start/end date30/05/19 → 31/12/19

Keywords

  • Neurological disorders
  • Alzheimer's disease
  • Clinical trial

Clinical Trial Phase

  • Phase I